Steris Plc Overview
Valuation check: STE's ROE is 11.15%, below the Healthcare sector average of 21.67%.
Get informed when a big investor buys or sells
+ Follow11.15%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Steris Plc (STE) currently reports a ROE of 11.15%. That is below the Healthcare sector average of 21.67%. Use the charts on this page to explore Steris Plc's ROE history and peer comparisons.
Steris Plc's ROE of 11.15% is lower than the Healthcare sector average of 21.67%. That is roughly 48.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Steris Plc's current 11.15% should be judged against Healthcare norms (sector average: 21.67%) and against STE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 11.15%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Steris Plc, and consider following STE for alerts when major investors trade the stock.
Steris Plc is classified in the Healthcare sector. On ROE, it currently shows 11.15% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing STE with unrelated industries.
